Protagonist Therapeutics Inc (PTGX)
Receivables turnover
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 315,090 | 60,137 | 123 | 123 | 982 | 26,704 | 35,221 | 45,507 | 46,913 | 27,380 | 24,330 | 27,139 | 31,091 | 28,549 | 25,678 | 12,604 | 6,408 | 4,321 | 3,955 | 10,051 |
Receivables | US$ in thousands | — | — | — | 50 | 51 | 3,852 | 620 | 3,363 | 28,504 | 5,333 | 4,509 | 9,855 | 5,819 | 3,821 | 3,324 | 3,273 | 3,747 | 7,499 | 2,118 | 6,310 |
Receivables turnover | — | — | — | 2.46 | 19.25 | 6.93 | 56.81 | 13.53 | 1.65 | 5.13 | 5.40 | 2.75 | 5.34 | 7.47 | 7.73 | 3.85 | 1.71 | 0.58 | 1.87 | 1.59 |
March 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $315,090K ÷ $—K
= —
The receivables turnover ratio for Protagonist Therapeutics Inc has shown fluctuation over the past quarters, ranging from as low as 0.58 to as high as 56.81. A higher receivables turnover ratio indicates that the company is efficiently collecting its accounts receivable and converting them into cash.
In the latest quarter, the receivables turnover ratio was 2.46, which suggests that the company took approximately 2.46 times to collect its accounts receivable during the period. This figure is lower compared to the previous quarter's ratio of 19.25, indicating a decrease in the efficiency of the company in collecting receivables.
It is essential for Protagonist Therapeutics Inc to monitor its receivables turnover ratio consistently and aim to improve it over time to ensure timely collection of outstanding payments from customers and maintain healthy cash flow.
Peer comparison
Mar 31, 2024